News

News

2018 BIO International Convention

26, Jun 2018

Holy Stone Healthcare Co., Ltd. attended 2018 BIO International Convention in Boston, USA on June 4-7.

During the exhibition, our two major developing products, IBD98-M & CA102N, were introduced. IBD98-M is a combination drug to treat mild to moderate Ulcerative Colitis, and CA102N is an anti-cancer drug-conjugate for targeted delivery to malignant cells.

previous page